$NVAX Balance Sheet | Understand Stock

$NVAX

$10.02 +$0.62 (6.54%) Live

$NVAX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Marketable securities
Restricted cash
Unbilled receivable
Accounts receivable
Inventory
Prepaid expenses and other current assets
Assets held for sale
Total current assets

Restricted cash
Property and equipment, net
Right of use asset, net
Intangible assets, net
Right-of-use asset, net
Goodwill
Other non-current assets
Total assets

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable
Accrued expenses
Deferred revenue
Current portion of finance lease liabilities
Convertible notes payable
Other current liabilities
Liabilities held for sale
Total current liabilities
Deferred revenue
Convertible notes payable
Long-term debt
Non-current finance lease liabilities
Other non-current liabilities
Total liabilities
Preferred stock, $0.01 par value, 2,000,000 shares authorized at September 30, 2021 and December 31, 2020; no shares issued and outstanding at September 30, 2021 and December 31, 2020
Preferred stock, $0.01 par value, 2,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025
Stockholders' deficit:
Common stock, $0.01 par value, 600,000,000 shares authorized at June 30, 2026 and December 31, 2025; 168,165,416 shares issued and 164,815,529 shares outstanding at June 30, 2026 and 164,969,773 shares issued and 162,575,937 shares outstanding at December 31, 2025
Additional paid-in capital
Accumulated deficit
Treasury stock, 766,631 shares, cost basis at December 31, 2022 and 591,980 shares, cost basis at December 31, 2021
Treasury stock, cost basis, 3,349,887 shares at June 30, 2026 and 2,393,836 shares at December 31, 2025
Accumulated other comprehensive income (loss)
Total stockholders’ deficit

Total liabilities and stockholders’ deficit

Comments